Akerna Corp. (KERN) Q3 2022 Earnings Call Transcript

Nov. 14, 2022 1:12 PM ETAkerna Corp. (KERN)
SA Transcripts profile picture
SA Transcripts

Akerna Corp. (NASDAQ:KERN) Q3 2022 Earnings Conference Call November 14, 2022 11:00 AM ET

Company Participants

Peter Seltzberg - Investor Relations

Jessica Billingsley - Chief Executive Officer & Chairman

Dean Ditto - Chief Financial Officer

Conference Call Participants

Ryan Kintslinger - Alliance Global


Good morning and welcome to Akerna’s Third Quarter 2022 Financial Results Conference Call. As a reminder, today’s call is being recorded. All participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]

At this time, I would like to turn the call over to Peter Seltzberg, Investor Relations for Akerna. Please go ahead, Peter.

Peter Seltzberg

Thank you, and welcome to today’s third quarter ended September 30, 2022 conference call. On the call today are Jessica Billingsley, CEO and Chairman of Akerna, and Dean Ditto, CFO of Akerna.

Before management begins with formal remarks, I’d like to remind everyone that during this conference call, certain statements will be made that are forward-looking within the meaning of the Safe Harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Words such as estimates, projected, expects, anticipates, forecasts, plans, intends, believes, seeks, may, will, should, future, propose, and variations of these words or similar expressions or versions of such words or expressions are intended to identify forward-looking statements. These statements include, but are not limited to statements regarding the future growth and prospects for Akerna and statements regarding expected future revenue recognition.

These forward-looking statements are not guarantees of future performance, conditions, or results and involve several known and unknown risks, uncertainties, assumptions and other important factors, which could cause actual results or outcomes to differ materially from those discussed, including risks related to changes in the cannabis market and risks related to the impact of the COVID-19 pandemic. These risk factors are more fully described

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.